Neurology

FDA Clears First Generic Version of Seizure Drug Sabril






Generic vigabatrin is indicated as add-on therapy for the treatment of complex partial seizures in patients aged 10 and older who are refractory to several other treatments.
FDA Approvals

Source link




Related posts

Presence of CHI3L1 and NFL in CSF Predicts Risk for Demyelinating Syndromes

Newsemia

fNCI-directed treatment of sports related post-concussion syndrome ion syndrome

Newsemia

clinical neurology; +159 new citations

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy